Emilia Scalzulli
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 102 publications
CD56+/CD38+ Neutrophils: Rapid and Specific Flow Cytometric Signature for Chronic Myeloid Leukemia.
Journal: Mediterranean journal of hematology and infectious diseases
Published: March 31, 2026
Diabetic Patients With Newly Diagnosed Chronic Myeloid Leukemia: TKI Choice and Early Adverse Events. A Real-Life Survey Within the Italian Chronic Myeloid Leukemia Network.
Journal: European journal of haematology
Published: February 24, 2026
Very long-term outcomes of chronic-phase chronic myeloid leukaemia patients treated with imatinib: A 25-year real-world cohort study.
Journal: British journal of haematology
Published: December 19, 2025
Early predictive factors of molecular relapse in chronic phase-chronic myeloid leukemia (CP-CML) patients after tyrosine kinase inhibitor (TKI) discontinuation.
Journal: Leukemia & lymphoma
Published: November 20, 2025
Hemoglobin changes during long-lasting frontline treatment with Tyrosine-Kinase inhibitors in patients with chronic myeloid leukemia.
Journal: Leukemia & lymphoma
Published: November 17, 2025
Second attempt to discontinue TKI after molecular relapse in patients with chronic myeloid leukemia: A real-life Italian multicenter study.
Journal: Cancer
Published: November 16, 2025
Rapid and accurate identification of acute promyelocytic leukemia with a novel multiparametric flow cytometric scoring system.
Journal: Haematologica
Published: September 14, 2025
Clinical Relevance and Prognostic Value of the Triple A (AAA) Score in Patients With Myelofibrosis (MF) Treated With Ruxolitinib (RUX).
Journal: European journal of haematology
Published: August 11, 2025
Increased Rate of Anemia and Discontinuation in Older Patients with Myelofibrosis Treated with Ruxolitinib.
Journal: Journal of clinical medicine
Published: July 30, 2025
Last Updated: 09/26/2026